New DNA test could speed up pneumonia diagnosis in ICU patients

NCT ID NCT05979350

Ongoing Diagnosis Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new DNA-sequencing technique (metagenomic next-generation sequencing) can identify the cause of pneumonia faster than standard methods. About 114 ICU patients on ventilators will be randomly assigned to receive either the new test or usual care. The goal is to see if faster diagnosis leads to better antibiotic use, shorter hospital stays, and lower death rates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: metagenomic next-generation sequencing (mNGS) test
What this could lead to: If successful, this could make pneumonia diagnosis faster and more accurate, helping doctors choose the right antibiotics sooner and potentially reducing hospital stays and deaths.
What could go wrong: This is a relatively small trial (114 participants) and focuses on diagnostic accuracy, not a new treatment. The test may not improve patient outcomes significantly, and its benefits may not apply to all pneumonia patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIAGNOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIAGNOSIS PNEUMONIA

Contacts and locations

Locations

National Taiwan University Hospital

Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.